Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001661539-23-000008

CHIEF MEDICAL OFFICER sold 2,252 shares at $20.00 ($45,040)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Trevejo Jose M. · CHIEF MEDICAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-20 Sale : show line 1 in the form 10b5-1 −2,252 $20.00 $45,040 2,251 D
Open-market sales · 2,252 sh · avg $20.00 · $45,040
Loading xslF345X05/wk-form4_1703284363.xml…